Evidence map›Paper›PMID 25834434›Full record

ArticleInternational journal of nanomedicine2015

Sensitive electrochemical immunosensor based on three-dimensional nanostructure gold electrode.

Guangxian Zhong, Ruilong Lan, Wenxin Zhang, Feihuan Fu, Yiming Sun, Huaping Peng, Tianbin Chen, Yishan Cai, Ailin Liu, Jianhua Lin and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Guangxian ZhongDepartment of Pharmaceutical Analysis, Faculty of Pharmacy, Fujian Medical University, Fuzhou, People's Republic of China ; Department of Orthopaedics, First Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China.
Ruilong LanThe Centralab, First Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China.
Wenxin ZhangDepartment of Pharmaceutical Analysis, Faculty of Pharmacy, Fujian Medical University, Fuzhou, People's Republic of China ; Nano Medical Technology Research Institute, Fujian Medical University, Fuzhou, People's Republic of China.
Feihuan FuDepartment of Endocrinology, The County Hospital of Anxi, Anxi, People's Republic of China.
Yiming SunDepartment of Pharmaceutical Analysis, Faculty of Pharmacy, Fujian Medical University, Fuzhou, People's Republic of China ; Nano Medical Technology Research Institute, Fujian Medical University, Fuzhou, People's Republic of China.
Huaping PengDepartment of Pharmaceutical Analysis, Faculty of Pharmacy, Fujian Medical University, Fuzhou, People's Republic of China ; Nano Medical Technology Research Institute, Fujian Medical University, Fuzhou, People's Republic of China.
Tianbin ChenThe Centralab, First Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China.
Yishan CaiFujian International Travel Healthcare Center, Fujian Entry-Exit Inspection and Quarantine Bureau, Fuzhou, People's Republic of China.
Ailin LiuDepartment of Pharmaceutical Analysis, Faculty of Pharmacy, Fujian Medical University, Fuzhou, People's Republic of China ; Nano Medical Technology Research Institute, Fujian Medical University, Fuzhou, People's Republic of China.
Jianhua LinDepartment of Orthopaedics, First Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China.
Xinhua LinDepartment of Pharmaceutical Analysis, Faculty of Pharmacy, Fujian Medical University, Fuzhou, People's Republic of China ; Nano Medical Technology Research Institute, Fujian Medical University, Fuzhou, People's Republic of China.
Fujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A sensitive electrochemical immunosensor was developed for detection of alpha-fetoprotein (AFP) based on a three-dimensional nanostructure gold electrode using a facile, rapid, "green" square-wave oxidation-reduction cycle technique. The resulting three-dimensional gold nanocomposites were characterized by scanning electron microscopy and cyclic voltammetry. A "sandwich-type" detection strategy using an electrochemical immunosensor was employed. Under optimal conditions, a good linear relationship between the current response signal and the AFP concentrations was observed in the range of 10-50 ng/mL with a detection limit of 3 pg/mL. This new immunosensor showed a fast amperometric response and high sensitivity and selectivity. It was successfully used to determine AFP in a human serum sample with a relative standard deviation of <5% (n=5). The proposed immunosensor represents a significant step toward practical application in clinical diagnosis and monitoring of prognosis.

Indexed as

Electrodesalpha-FetoproteinsAntibodiesBiosensing TechniquesElectrochemical TechniquesEquipment DesignGoldHumansLimit of DetectionMicroscopy, Electron, ScanningNanocompositesReproducibility of ResultsSensitivity and Specificityalpha-FetoproteinsAntibodiesGoldalpha-fetoproteinelectrochemical immunosensorssquare-wave oxidation-reduction cyclethree-dimensional nanostructure gold electrode

Identifiers

PMID25834434
PMCPMC4372010
OpenAlexW2083578160

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.